Clinical Trial Update: PGC-1 & Muscle Mitochondrial Dysfunction in Diabetes [NA]

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial assessing PGC-1 and muscle mitochondrial dysfunction in diabetes mellitus and obesity has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Obesity

Snippet

Sponsor: Mayo Clinic | Conditions: Diabetes, Obesity | NA | Status: TERMINATED